URF-46558-37819
3 vaccinations
2 coded responses
37 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 280 / NC
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-09
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
-
2021-04-28
Dose 2 — Pfizer-BioNTech
-
2021-04-28
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-30
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-07-28
- 2021-10-29
-
2021-10-30
Dose 3 — Pfizer-BioNTech
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-04
- 2021-11-05
- 2021-11-08
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-06
- 2021-12-11
-
2022-01-29
Survey response — 3 months, dose 3MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Be unable to work or attend schoolFree text: Tested positive for COVID-19MedDRA releases: 2024-11 · check-in free text available
- 2022-05-02
-
2022-11-01
Survey response — 12 months, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Extreme fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-11-01
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2021-10-30 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-01 | Unsuccessful |
Free text
Release 11 — 3 months, dose 3
Symptoms: Tested positive for COVID-19
Release 12 — 12 months, dose 3
Symptoms: Extreme fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release